In 2005, Ryan joined the medical device equity research team at RBC Capital Markets and later became the lead analyst for three companies in the cardiology space – CryoCath, Thoratec, and ATS Medical. In addition, he supported the senior analyst in covering all strategic cardiology companies, including St Jude Medical (now part of Abbott), Boston Scientific, Medtronic, and Johnson & Johnson. His responsibilities included industry analysis, financial modeling, and authoring research reports on companies under coverage. Key activities included participating on quarterly conference calls with management teams, attending company-hosted investor events, and traveling to major medical congresses. Insights gained from these collective activities provided the foundation for all research reports he authored as an analyst.

Building on his experience as an analyst, Ryan joined Biosense Webster, Inc. (BWI) in 2010. BWI is the recognized market leader in cardiac ablation and is a part of the Johnson & Johnson family of companies. Over the subsequent 12+ years, Ryan held various roles of increasing responsibilities in the Global Strategic Marketing organization. Across all roles, he led the competitive intelligence function at BWI and was responsible for collecting, analyzing, and reporting market insights from all publicly available sources. He presented findings to the BWI Global Management Board and functional leadership teams across the company. For EP industry congresses, Ryan led all competitive intelligence activities and presented daily updates to company attendees at the event. In his most recent role, Ryan led the BWI Strategic Planning process, which involved an annual environmental scan analyzing not only competitive updates but also trends across the AF market. These collective market insights were then utilized to generate actionable strategic recommendations for the business.